OPTIMIZERx

Yahoo Finance • 4 days ago

OptimizeRx Appoints Mary Varghese Presti to Board of Directors

OptimizeRx Corporation Microsoft Health & Life Sciences COO brings expertise in scaling healthcare platforms, commercializing new technologies, and driving operational efficiency WALTHAM, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- Optimiz... Full story

Yahoo Finance • last month

UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

-   Q4 revenue of $32.2 million-   Q4 gross profit increased 9% year-over-year to $24.1 million-   Q4 net income and adjusted EBITDA hit records at $5.0 million and $12.0 million, respectively-   Updating 2026 revenue guidance to $109-$114... Full story

Yahoo Finance • last month

Quant snapshot: Impala Platinum, Turkcell Iletisim lead strong buys as Evolus lag

Information Technology stocks lead the pack on quant strength in the latest screen, posting the highest average ratings among the sectors listed, while Health Care names rank at the bottom. The single highest-rated stock overall is Impala... Full story

Yahoo Finance • 2 months ago

Whetstone Dumps 79,000 monday.com Shares Worth $15.3 Million

On February 13, 2026, Whetstone Capital Advisors, LLC disclosed in a U.S. Securities and Exchange Commission (SEC) filing that it sold out its entire position in monday.com Ltd.(NASDAQ:MNDY). What happened According to a filing with the... Full story

Yahoo Finance • 4 months ago

OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network

WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and... Full story

Yahoo Finance • 4 months ago

BrightView Shares Down 30%: What a Full Fund Exit Signals for Investors

Key Points Connecticut-based Manatuck Hill Partners sold 367,000 shares of BrightView Holdings in the third quarter. The position was previously worth about $7.8 million. The move marked an exit, with no reported BrightView holdings at qu... Full story

Yahoo Finance • 4 months ago

Why One Fund Still Has a $14 Million Bet on This Resale Stock Up 130% This Past Year

Key Points Connecticut-based Manatuck Hill Partners sold 350,000 shares of The RealReal in the third quarter. The position value decreased by an estimated $5.8 million versus the prior quarter. Manatuck now holds nearly 1.3 million shares... Full story

Yahoo Finance • 4 months ago

Why One Fund Added 415,000 Shares of a Software Stock Down 26% This Past Year

Key Points Connecticut-based Manatuck Hill Partners bought 415,000 shares of Zeta Global in the third quarter. The value of the overall stake increased by about $9.5 million during the period. The fund now holds 705,000 Zeta shares valued... Full story

Yahoo Finance • 4 months ago

This Fund Just Bought $6 Million in Plug Power Stock — Is a Turnaround in Sight?

Key Points Connecticut-based Manatuck Hill Partners acquired 2.5 million shares of Plug Power in the third quarter. The position value increased by about $5.8 million from quarter to quarter. As of September 30, Manatuck reported holding... Full story

Yahoo Finance • 6 months ago

OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET

WALTHAM, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and... Full story

Yahoo Finance • 6 months ago

These Were the Russell 2000 Stocks That Dominated In Q3 2025

The small cap-focused Russell 2000 index has spent years lagging behind the larger S&P 500 and Nasdaq 100 indexes, but in third-quarter 2025 it took a big leap back to parity with large caps. Thanks to interest-rate-cut bets and optimism... Full story

Yahoo Finance • 7 months ago

OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference

WALTHAM, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) an... Full story

Yahoo Finance • 7 months ago

OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising

Strategic Partnership Combines OptimizeRx's Patented Micro-Neighborhood® Targeting Data with Lamar’s Vast Nationwide OOH Network to Strengthen OOH Media for Healthcare Marketing WALTHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Optimiz... Full story

Yahoo Finance • 7 months ago

OptimizeRx Corp (NASDAQ:OPRX) Combines Technical Strength with High-Growth Momentum

In the world of growth investing, combining technical strength with fundamental momentum can be a good method for finding high-potential stocks. The method used here brings together Mark Minervini’s Trend Template, a strict group of techni... Full story

Yahoo Finance • 7 months ago

Stock Market Today: Nasdaq Up, S&P 500 Etches Record High As Lumentum Soars; Nvidia Ends Well Off Lows (Live Coverage)

The Nasdaq leads upside with a moderate gain while the S&P 500 hits an all-time high. Nvidia trims losses bullishly; Pure Storage executes a breakaway gap. Continue Reading View Comments... Full story

Yahoo Finance • 8 months ago

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth

WALTHAM, Mass., Aug. 19, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and... Full story

Yahoo Finance • 8 months ago

OptimizeRX price target raised to $20 from $14 at JMP on strong earnings

Investing.com - JMP Securities raised its price target on OptimizeRX (NASDAQ:OPRX) to $20.00 from $14.00 on Monday, while maintaining a Market Outperform rating following the company’s strong second-quarter results. According to InvestingP... Full story

Yahoo Finance • 8 months ago

OptimizeRx raises 2025 revenue guidance to $104M-$108M as contracted revenue climbs 30%

Earnings Call Insights: OptimizeRx Corporation (OPRX) Q2 2025 MANAGEMENT VIEW * CEO Stephen L. Silvestro opened the call highlighting that "Q2 revenues increasing 55% year-over-year to $29.2 million, with adjusted EBITDA coming in at $... Full story

Yahoo Finance • 8 months ago

OptimizeRx Corp (NASDAQ:OPRX) Surges 15% After Blowout Q2 Earnings and Raised 2025 Guidance

OptimizeRx Corp. (NASDAQ:OPRX [https://www.chartmill.com/stock/quote/OPRX]) reported second-quarter 2025 financial results that significantly exceeded analyst expectations, driving a sharp positive reaction in after-hours trading. The heal... Full story

Yahoo Finance • 8 months ago

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

Q2 revenue of $29.2 million, increased 55% year-over-yearQ2 gross profit increased 59% year-over-year to $18.6 millionPaid down $4.5 million of principal on outstanding term loan during Q2Increased full year 2025 guidance to a revenue rang... Full story